Skip to main content

Find Clinical Trials

Home
Conditions
Hypersensitivity

Clinical trial condition

Hypersensitivity

Explore clinical trials studying Hypersensitivity. Study availability and eligibility vary by location and protocol.

6,753 public trials 646 recruiting studies

Refine in advanced search Browse all conditions

Hypersensitivity trial results

Completed

Study HZA106829: Efficacy/Safety Study of Fluticasone Furoate/Vilanterol (GW642444) in Adult and Adolescent Asthmatics

NCT01134042

Conditions: Asthma, Bronchial Diseases, Hypersensitivity, +6 more
Locations: GSK Investigational Site Bell Gardens, California, United States

GSK Investigational Site Huntington Beach, California, United States

GSK Investigational Site Long Beach, California, United States

GSK Investigational Site Los Angeles, California, United States

View all 71 locations

View Trial Details

Completed

Dose Ranging Pharmacokinetics and Pharmacodynamics Study With Mepolizumab in Asthma Patients With Elevated Eosinophils

NCT01366521

Conditions: Asthma, Bronchial Diseases, Hypersensitivity, +6 more
Locations: GSK Investigational Site Winston-Salem, North Carolina, United States

GSK Investigational Site Pittsburgh, Pennsylvania, United States

GSK Investigational Site Tallinn, Estonia

GSK Investigational Site Tartu, Estonia

View Trial Details

Completed

Responses to Immunization With Keyhole Limpet Hemocyanin Administered by Scarification and the Intradermal Route

NCT00614731

Conditions: Atopic Dermatitis, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Dermatitis, +9 more
Locations: National Jewish Health Denver, Colorado, United States

View Trial Details

Completed

A Study to Compare the Effects of Different Sized Particles on Cells in the Nose

NCT01257191

Conditions: Atopic Hypersensitivity, Hypersensitivity, Hypersensitivity, Immediate, +1 more
Locations: University of California, Los Angeles Los Angeles, California, United States

View Trial Details

Completed

Comparison of Cathelicidin Expression in Skin and Saliva in Patients With Atopic Dermatitis and Psoriasis

NCT00407979

Conditions: Atopic Dermatitis, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Dermatitis, +11 more
Locations: University of California, San Diego San Diego, California, United States

National Jewish Health Denver, Colorado, United States

View Trial Details

Completed

A Study in Asthmatic Patients to Determine if There is Any Difference in Dosing With Fluticasone Furoate/Vilanterol Inhalation Powder in the Morning or Evening on Lung Function

NCT01287065

Conditions: Asthma, Bronchial Diseases, Hypersensitivity, +6 more
Locations: GSK Investigational Site Wellington, New Zealand

View Trial Details

Completed

Tolerance Evaluation of a Nighttime Moisturizing Balm on Babies and Adults With Eczema

NCT02357940

Conditions: Atopic Dermatitis (AD), Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Dermatitis, +10 more
Locations: Hill-top Research, Inc St. Petersburg, Florida, United States

TKL Research Inc. Fair Lawn, New Jersey, United States

View Trial Details

Completed

Untersuchung Zur Erfassung Und Kontrolle Der Lebensqualität Unter Einer Therapie Mit Pollinex Quattro Bei Heuschnupfen

NCT03014661

Conditions: Hypersensitivity, Hypersensitivity, Immediate, Immune System Diseases, +7 more
Locations: Saarland University Hospital. Department of Dermatology Homburg, Saarland, Germany

View Trial Details

Completed

Clinical Study Evaluating Safety and Efficacy of Fluticasone Furoate and Fluticasone Propionate in People With Asthma

NCT01436110

Conditions: Asthma, Bronchial Diseases, Hypersensitivity, +6 more
Locations: GSK Investigational Site Los Angeles, California, United States

GSK Investigational Site Rolling Hills Estates, California, United States

GSK Investigational Site Sacramento, California, United States

GSK Investigational Site San Jose, California, United States

View all 42 locations

View Trial Details

Completed

Dose-ranging Study of Vilanterol (VI) Inhalation Powder in Children

NCT01573767

Conditions: Asthma, Bronchial Diseases, Hypersensitivity, +6 more
Locations: GSK Investigational Site Birmingham, Alabama, United States

GSK Investigational Site Mobile, Alabama, United States

GSK Investigational Site Little Rock, Arkansas, United States

GSK Investigational Site Huntington Beach, California, United States

View all 120 locations

View Trial Details